2023 Q1 Form 10-K Financial Statement
#000121390023024977 Filed on March 31, 2023
Income Statement
| Concept | 2023 Q1 | 2022 Q4 | 2022 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $160.0K | $170.0K | $660.0K |
| YoY Change | 73.91% | -65.16% | -59.73% |
| % of Gross Profit | |||
| Research & Development | $233.0K | $179.0K | $673.0K |
| YoY Change | 258.46% | -61.75% | -26.13% |
| % of Gross Profit | |||
| Depreciation & Amortization | $10.00K | $2.000K | $38.00K |
| YoY Change | 66.67% | -60.0% | 533.33% |
| % of Gross Profit | |||
| Operating Expenses | $233.0K | $349.0K | $673.0K |
| YoY Change | 48.41% | -63.49% | -73.61% |
| Operating Profit | -$393.0K | -$1.333M | |
| YoY Change | 150.32% | -47.73% | |
| Interest Expense | $77.00K | -$363.0K | -$480.0K |
| YoY Change | -86.68% | 611.76% | -65.49% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $77.00K | -$480.0K | |
| YoY Change | -86.68% | -65.49% | |
| Pretax Income | -$316.0K | -$712.0K | -$1.813M |
| YoY Change | -175.06% | -29.29% | -54.0% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$186.0K | -$631.0K | -$1.813M |
| YoY Change | -144.18% | -23.98% | -49.9% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | -$0.04 | -$0.36 | |
| Diluted Earnings Per Share | -$0.04 | -$0.15 | -$0.36 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 4.216M shares | 4.194M shares | 4.194M shares |
| Diluted Shares Outstanding | 4.216M shares | 4.194M shares |
Balance Sheet
| Concept | 2023 Q1 | 2022 Q4 | 2022 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $1.400M | $810.0K | $810.0K |
| YoY Change | 296.6% | -6.47% | -6.47% |
| Cash & Equivalents | $1.400M | $810.0K | $810.0K |
| Short-Term Investments | |||
| Other Short-Term Assets | $75.00K | $85.00K | $91.00K |
| YoY Change | -64.45% | 10.39% | -6.19% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $1.481M | $901.0K | $901.0K |
| YoY Change | 162.59% | -6.44% | -6.44% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $239.0K | $219.0K | $249.0K |
| YoY Change | 7.17% | 3550.0% | 378.85% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | |||
| YoY Change | |||
| Total Long-Term Assets | $265.0K | $249.0K | $249.0K |
| YoY Change | 18.83% | 378.85% | 378.85% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $1.481M | $901.0K | $901.0K |
| Total Long-Term Assets | $265.0K | $249.0K | $249.0K |
| Total Assets | $1.746M | $1.150M | $1.150M |
| YoY Change | 121.86% | 13.3% | 13.3% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $42.00K | $55.00K | $55.00K |
| YoY Change | 44.83% | 358.33% | 358.33% |
| Accrued Expenses | $30.00K | $32.00K | $32.00K |
| YoY Change | 50.0% | 60.0% | 60.0% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $1.952M | $2.145M | $2.145M |
| YoY Change | 51.44% | -28.36% | -28.36% |
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $3.283M | $3.719M | $3.719M |
| YoY Change | 19.99% | 10.75% | 10.75% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | |
| YoY Change | |||
| Other Long-Term Liabilities | $0.00 | $0.00 | |
| YoY Change | -100.0% | -100.0% | |
| Total Long-Term Liabilities | $0.00 | $0.00 | |
| YoY Change | -100.0% | -100.0% | |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.283M | $3.719M | $3.719M |
| Total Long-Term Liabilities | $0.00 | $0.00 | |
| Total Liabilities | $3.283M | $3.719M | $3.994M |
| YoY Change | 16.09% | 9.8% | 14.34% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$22.79M | -$22.60M | |
| YoY Change | 7.24% | ||
| Common Stock | $4.000K | $4.000K | |
| YoY Change | 0.0% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$2.203M | -$2.844M | -$2.844M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $1.746M | $1.150M | $1.150M |
| YoY Change | 121.86% | 13.3% | 13.3% |
Cashflow Statement
| Concept | 2023 Q1 | 2022 Q4 | 2022 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$186.0K | -$631.0K | -$1.813M |
| YoY Change | -144.18% | -23.98% | -49.9% |
| Depreciation, Depletion And Amortization | $10.00K | $2.000K | $38.00K |
| YoY Change | 66.67% | -60.0% | 533.33% |
| Cash From Operating Activities | -$417.0K | -$253.0K | -$986.0K |
| YoY Change | 60.38% | 427.08% | -28.24% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $26.00K | $7.000K | $206.0K |
| YoY Change | -114.69% | 40.0% | -3042.86% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $5.000K | $14.00K | |
| YoY Change | -600.0% | -170.0% | |
| Cash From Investing Activities | -$26.00K | -$2.000K | -$192.0K |
| YoY Change | -85.31% | -150.0% | 611.11% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | $1.033M | 874.0K | $1.122M |
| YoY Change | -1344.58% | -14666.67% | -39.55% |
| NET CHANGE | |||
| Cash From Operating Activities | -$417.0K | -253.0K | -$986.0K |
| Cash From Investing Activities | -$26.00K | -2.000K | -$192.0K |
| Cash From Financing Activities | $1.033M | 874.0K | $1.122M |
| Net Change In Cash | $590.0K | 619.0K | -$56.00K |
| YoY Change | -213.46% | -1338.0% | -112.31% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$417.0K | -$253.0K | -$986.0K |
| Capital Expenditures | $26.00K | $7.000K | $206.0K |
| Free Cash Flow | -$443.0K | -$260.0K | -$1.192M |
| YoY Change | 433.73% | 390.57% | -12.8% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
370000 | shares |
| CY2022 | dei |
Document Type
DocumentType
|
10-K | |
| CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
| CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
| CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
| CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
| CY2022 | dei |
Entity File Number
EntityFileNumber
|
333-208814 | |
| CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
SATIVUS TECH CORP. | |
| CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
| CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
47-2847446 | |
| CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
#3 Bethesda Metro Center | |
| CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
#700 | |
| CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Bethesda | |
| CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
06880 | |
| CY2022 | dei |
City Area Code
CityAreaCode
|
(800) | |
| CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
608-6432 | |
| CY2022 | dei |
Trading Symbol
TradingSymbol
|
NA | |
| CY2022 | dei |
Security12g Title
Security12gTitle
|
Common Stock, par value $0.0001 | |
| CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
No | |
| CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
| CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
| CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
| CY2022 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
| CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
| CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4215571 | shares |
| CY2022 | dei |
Auditor Name
AuditorName
|
Halperin Ilanit | |
| CY2022 | dei |
Auditor Firm
AuditorFirmId
|
650100001 | |
| CY2022 | dei |
Auditor Location
AuditorLocation
|
Tel Aviv, Israel | |
| CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
810000 | usd |
| CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
866000 | usd |
| CY2022Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
6000 | usd |
| CY2021Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
20000 | usd |
| CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
85000 | usd |
| CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
77000 | usd |
| CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
901000 | usd |
| CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
963000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
30000 | usd |
| CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
46000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
219000 | usd |
| CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
6000 | usd |
| CY2022Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
249000 | usd |
| CY2021Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
52000 | usd |
| CY2022Q4 | us-gaap |
Assets
Assets
|
1150000 | usd |
| CY2021Q4 | us-gaap |
Assets
Assets
|
1015000 | usd |
| CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
55000 | usd |
| CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
12000 | usd |
| CY2022Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
114000 | usd |
| CY2022Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
2031000 | usd |
| CY2021Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
2994000 | usd |
| CY2022Q4 | satt |
Fair Value Of Convertible Component In Convertible Loan
FairValueOfConvertibleComponentInConvertibleLoan
|
1327000 | usd |
| CY2021Q4 | satt |
Fair Value Of Convertible Component In Convertible Loan
FairValueOfConvertibleComponentInConvertibleLoan
|
222000 | usd |
| CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
160000 | usd |
| CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
110000 | usd |
| CY2022Q4 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
32000 | usd |
| CY2021Q4 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
20000 | usd |
| CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3719000 | usd |
| CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3358000 | usd |
| CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
29000 | usd |
| CY2021Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
29000 | usd |
| CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4215571 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4215571 | shares |
| CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4204385 | shares |
| CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4204385 | shares |
| CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4000 | usd |
| CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4000 | usd |
| CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
19756000 | usd |
| CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
18595000 | usd |
| CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-22604000 | usd |
| CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-21077000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2844000 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2478000 | usd |
| CY2022Q4 | us-gaap |
Minority Interest
MinorityInterest
|
275000 | usd |
| CY2021Q4 | us-gaap |
Minority Interest
MinorityInterest
|
106000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2569000 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2372000 | usd |
| CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1150000 | usd |
| CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1015000 | usd |
| CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
673000 | usd |
| CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
911000 | usd |
| CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
660000 | usd |
| CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1639000 | usd |
| CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1333000 | usd |
| CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2550000 | usd |
| CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-480000 | usd |
| CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1391000 | usd |
| CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1813000 | usd |
| CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3941000 | usd |
| CY2022 | satt |
Noncontrolling Interests
NoncontrollingInterests
|
-286000 | usd |
| CY2021 | satt |
Noncontrolling Interests
NoncontrollingInterests
|
-322000 | usd |
| CY2022 | us-gaap |
Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
|
-1527000 | usd |
| CY2021 | us-gaap |
Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
|
-3619000 | usd |
| CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.36 | |
| CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1 | |
| CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4194443 | shares |
| CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3607476 | shares |
| CY2020Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2046000 | usd |
| CY2021 | satt |
Stock Issued During Period Value Transactions With Noncontrolling Parties
StockIssuedDuringPeriodValueTransactionsWithNoncontrollingParties
|
1355000 | usd |
| CY2021 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
51000 | usd |
| CY2021 | satt |
Share Based Compensation To Employees And Nonemployee
ShareBasedCompensationToEmployeesAndNonemployee
|
710000 | usd |
| CY2021 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
831000 | usd |
| CY2021 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
608000 | usd |
| CY2021 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
60000 | usd |
| CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3941000 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2372000 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2372000 | usd |
| CY2022 | satt |
Stock Issued During Period Value Transactions With Noncontrolling Parties
StockIssuedDuringPeriodValueTransactionsWithNoncontrollingParties
|
1308000 | usd |
| CY2022 | us-gaap |
Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
|
211000 | usd |
| CY2022 | satt |
Share Based Compensation To Employees And Nonemployee
ShareBasedCompensationToEmployeesAndNonemployee
|
374000 | usd |
| CY2022 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
133000 | usd |
| CY2022 | satt |
Issuance Of Shares In Respect Of Converted Safe In Subsidiary Value
IssuanceOfSharesInRespectOfConvertedSAFEInSubsidiaryValue
|
12000 | usd |
| CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1813000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2569000 | usd |
| CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-1813000 | usd |
| CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-3941000 | usd |
| CY2022 | us-gaap |
Depreciation
Depreciation
|
38000 | usd |
| CY2021 | us-gaap |
Depreciation
Depreciation
|
6000 | usd |
| CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
267000 | usd |
| CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1318000 | usd |
| CY2022 | satt |
Financial Expenses Related To Loans From Related Party
FinancialExpensesRelatedToLoansFromRelatedParty
|
320000 | usd |
| CY2021 | satt |
Financial Expenses Related To Loans From Related Party
FinancialExpensesRelatedToLoansFromRelatedParty
|
2232000 | usd |
| CY2022 | satt |
Change In Fair Value Of Convertible Component In Convertible Loan
ChangeInFairValueOfConvertibleComponentInConvertibleLoan
|
117000 | usd |
| CY2021 | satt |
Change In Fair Value Of Convertible Component In Convertible Loan
ChangeInFairValueOfConvertibleComponentInConvertibleLoan
|
-890000 | usd |
| CY2022 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
8000 | usd |
| CY2021 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
70000 | usd |
| CY2022 | us-gaap |
Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
|
43000 | usd |
| CY2021 | us-gaap |
Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
|
-39000 | usd |
| CY2022 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
50000 | usd |
| CY2021 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
10000 | usd |
| CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-986000 | usd |
| CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1374000 | usd |
| CY2022 | satt |
Increases In Restricted Cash
IncreasesInRestrictedCash
|
-14000 | usd |
| CY2021 | satt |
Increases In Restricted Cash
IncreasesInRestrictedCash
|
20000 | usd |
| CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
206000 | usd |
| CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
7000 | usd |
| CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-192000 | usd |
| CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-27000 | usd |
| CY2021 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
530000 | usd |
| CY2022 | us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
114000 | usd |
| CY2022 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
22000 | usd |
| CY2021 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
6000 | usd |
| CY2022 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
1308000 | usd |
| CY2021 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
1406000 | usd |
| CY2022 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
278000 | usd |
| CY2021 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
74000 | usd |
| CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1122000 | usd |
| CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1856000 | usd |
| CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-56000 | usd |
| CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
455000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
866000 | usd |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
411000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
810000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
866000 | usd |
| CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
175000 | usd |
| CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
74000 | usd |
| CY2021 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
830000 | usd |
| CY2021 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
60000 | usd |
| CY2021 | satt |
Right Of Use Asset
RightOfUseAsset
|
52000 | usd |
| CY2022Q4 | satt |
Retained Earning Accumulated Deficit
RetainedEarningAccumulatedDeficit
|
22649000 | usd |
| CY2022 | satt |
Operating Cash Flow
OperatingCashFlow
|
986000 | usd |
| CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of estimates:</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
| CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
268000 | usd |
| CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1318000 | usd |
| CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration of credit risks:</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents and restricted bank deposit. Cash and cash equivalents and restricted bank deposit are invested in major banks in Israel and the United States. Such funds in the Israel may be in excess of insured limits and are not insured in other jurisdictions. Management believes that the financial institutions that hold the Company and its subsidiary’ cash and cash equivalents have high credit ratings.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
| CY2022 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
362000 | usd |
| CY2022Q4 | us-gaap |
Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
|
618000 | usd |
| CY2022Q4 | us-gaap |
Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
|
153000 | usd |
| CY2021 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
234000 | usd |
| CY2021 | us-gaap |
Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards
EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
|
1523000 | usd |
| CY2021Q4 | us-gaap |
Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
|
1757000 | usd |
| CY2021Q4 | us-gaap |
Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
|
107000 | usd |
| CY2021Q4 | us-gaap |
Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
|
6000 | usd |
| CY2022Q4 | us-gaap |
Federal Home Loan Bank Borrowings Fair Value Disclosure
FederalHomeLoanBankBorrowingsFairValueDisclosure
|
1327000 | usd |
| CY2022Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
1327000 | usd |
| CY2021Q4 | us-gaap |
Federal Home Loan Bank Borrowings Fair Value Disclosure
FederalHomeLoanBankBorrowingsFairValueDisclosure
|
222000 | usd |
| CY2021Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
222000 | usd |
| CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.50 | pure |
| CY2021Q4 | satt |
Additional Services
AdditionalServices
|
3000 | usd |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
|
72000 | usd |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
|
56000 | usd |
| CY2021Q4 | us-gaap |
Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
|
11300 | usd |
| CY2022 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
326000 | usd |
| CY2021Q2 | satt |
Accrued Interest
AccruedInterest
|
60000 | usd |
| CY2021Q2 | satt |
Loan Amount
LoanAmount
|
14000 | usd |
| CY2022Q1 | satt |
Loan Amount
LoanAmount
|
20000 | usd |
| CY2020Q3 | us-gaap |
Loans Payable
LoansPayable
|
100000 | usd |
| CY2020Q3 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2022-07-31 | |
| CY2020Q3 | us-gaap |
Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
|
0.10 | pure |
| CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
18 | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
129000 | usd |
| CY2022 | satt |
Revalued Values Of Bcf
RevaluedValuesOfBcf
|
88000 | usd |
| CY2021 | satt |
Revalued Values Of Bcf
RevaluedValuesOfBcf
|
76000 | usd |
| CY2022Q4 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
51000 | usd |
| CY2021Q4 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
27000 | usd |
| CY2022 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
283000 | usd |
| CY2022 | us-gaap |
Employee Service Share Based Compensation Cash Flow Effect Cash Used To Settle Awards
EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
|
335000 | usd |
| CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2022Q4 | satt |
Common Stock Shares Issued And Outstanding
CommonStockSharesIssuedAndOutstanding
|
4215571 | shares |
| CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2021Q4 | satt |
Common Stock Shares Issued And Outstanding
CommonStockSharesIssuedAndOutstanding
|
4194385 | shares |
| satt |
Issuance Of Shares
IssuanceOfShares
|
830000 | shares | |
| CY2021Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
830000 | usd |
| CY2021Q3 | satt |
Number Of Directors
NumberOfDirectors
|
3 | pure |
| CY2021Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
47134 | shares |
| CY2021Q3 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
106000 | usd |
| CY2022Q4 | us-gaap |
Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
|
21186 | shares |
| CY2022 | satt |
Schedule Of Warrant Activity
ScheduleOfWarrantActivity
|
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average<br/> exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-indent: -9pt; padding-left: 9pt">Warrants outstanding at January 1, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">213,083</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8.10</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 0.25in">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 0.25in">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(66,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(47,333</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">19.40</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt">Warrants outstanding at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">198,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 0.25in">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 0.25in">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Forfeited /Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt">Warrants outstanding at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">119,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5.88</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | |
| CY2020Q4 | satt |
Number Of Warrant Outstanding
NumberOfWarrantOutstanding
|
213083 | shares |
| CY2020Q4 | satt |
Average Exercise Price Warrant Outstanding
AverageExercisePriceWarrantOutstanding
|
8.1 | |
| CY2021 | satt |
Number Warrant Granted
NumberWarrantGranted
|
99000 | shares |
| CY2021 | satt |
Average Exercise Price Warrants Granted
AverageExercisePriceWarrantsGranted
|
1.5 | |
| CY2021 | satt |
Number Warrant Forfeited Cancelled
NumberWarrantForfeitedCancelled
|
-66000 | shares |
| CY2021 | satt |
Average Exercise Price Forfeited Cancelled
AverageExercisePriceForfeitedCancelled
|
1.5 | |
| CY2021 | satt |
Number Warrants Forfeited Cancelled
NumberWarrantsForfeitedCancelled
|
-47333 | shares |
| CY2021 | satt |
Average Exercise Prices Forfeited Cancelled
AverageExercisePricesForfeitedCancelled
|
19.4 | |
| CY2021Q4 | satt |
Number Of Warrant Outstanding
NumberOfWarrantOutstanding
|
198750 | shares |
| CY2021Q4 | satt |
Average Exercise Price Warrant Outstanding
AverageExercisePriceWarrantOutstanding
|
5.4 | |
| CY2022 | satt |
Number Warrants Forfeited Cancelled
NumberWarrantsForfeitedCancelled
|
-13750 | shares |
| CY2022 | satt |
Average Exercise Prices Forfeited Cancelled
AverageExercisePricesForfeitedCancelled
|
2 | |
| CY2022 | satt |
Number Warrant Forfeited Cancelled
NumberWarrantForfeitedCancelled
|
-66000 | shares |
| CY2022 | satt |
Average Exercise Price Forfeited Cancelled
AverageExercisePriceForfeitedCancelled
|
1.5 | |
| CY2022Q4 | satt |
Number Of Warrant Outstanding
NumberOfWarrantOutstanding
|
119000 | shares |
| CY2022Q4 | satt |
Average Exercise Price Warrant Outstanding
AverageExercisePriceWarrantOutstanding
|
5.88 | |
| CY2022Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
119000 | shares |
| CY2022 | satt |
Class Of Warrant Or Righst Warrants Or Rights Exercisable
ClassOfWarrantOrRighstWarrantsOrRightsExercisable
|
119000 | shares |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
166000 | shares |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.1 | |
| CY2021 | satt |
Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
120000 | shares |
| CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.01 | |
| CY2021 | satt |
Number Options Exercised
NumberOptionsExercised
|
90000 | shares |
| CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.1 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
1000 | shares |
| CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
3 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
195000 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.63 | |
| CY2022 | satt |
Shares Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
45000 | shares |
| CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1 | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
240000 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.7 | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
206250 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.73 | |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
240000 | shares |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
206250 | shares |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
49025 | shares |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
227500 | shares |
| CY2021 | satt |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised
|
-80525 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
196000 | shares |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
30000 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
536000 | shares |
| CY2021Q1 | satt |
Number Of Directors
NumberOfDirectors
|
2 | pure |
| CY2021Q1 | satt |
Restricted Stock Unit Shares Issued
RestrictedStockUnitSharesIssued
|
30000 | shares |
| CY2021Q1 | us-gaap |
Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
|
334000 | usd |
| CY2020Q4 | satt |
Restricted Stock Unit Shares Issued
RestrictedStockUnitSharesIssued
|
7500 | shares |
| CY2020Q4 | us-gaap |
Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
|
18000 | usd |
| CY2021Q4 | us-gaap |
Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
|
111000 | usd |
| CY2021Q4 | satt |
Rs Us Vest Quarterly Years
RSUsVestQuarterlyYears
|
P1Y | |
| CY2022Q4 | us-gaap |
Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
|
122000 | usd |
| CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.23 | pure |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.23 | pure |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
1686000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
1412000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
1686000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
1412000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
1686000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
1412000 | usd |
| CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
7851000 | usd |
| CY2022 | us-gaap |
Payments For Commissions
PaymentsForCommissions
|
13000 | usd |
| CY2021 | us-gaap |
Payments For Commissions
PaymentsForCommissions
|
2000 | usd |
| CY2022 | satt |
Financial Expenses Related To Interest And Revaluation
FinancialExpensesRelatedToInterestAndRevaluation
|
-420000 | usd |
| CY2021 | satt |
Financial Expenses Related To Interest And Revaluation
FinancialExpensesRelatedToInterestAndRevaluation
|
890000 | usd |
| CY2021 | us-gaap |
Payments For Loans
PaymentsForLoans
|
98000 | usd |
| CY2022 | satt |
Expenses Due To Change In Fair Value Of Warrant
ExpensesDueToChangeInFairValueOfWarrant
|
-11000 | usd |
| CY2021 | satt |
Expenses Due To Change In Fair Value Of Warrant
ExpensesDueToChangeInFairValueOfWarrant
|
2232000 | usd |
| CY2022 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
58000 | usd |
| CY2021 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-51000 | usd |
| CY2022 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
480000 | usd |
| CY2021 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
1391000 | usd |
| CY2022Q4 | us-gaap |
Investment Maturity Date
InvestmentMaturityDate
|
2024-09-11 | |
| CY2022 | us-gaap |
Facility Costs
FacilityCosts
|
2000 | usd |
| CY2022Q4 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
23000 | usd |
| CY2022 | us-gaap |
Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
|
In the first 3 years of sales the Company shall pay 3% of the sales of the product which was developed under IIA research and development projects. In the fourth, fifth and sixth years of sales, the Company shall pay 4% of such sales and from the seventh year onwards the Company shall pay 5% of up to 100% of the amount of grants received plus interest at LIBOR. | |
| CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
usd | |
| CY2022Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
usd | |
| CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3607476 | shares |
| CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4194443 | shares |
| CY2021 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
usd | |
| CY2021 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
usd | |
| CY2022 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
usd | |
| CY2021 | us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
usd | |
| CY2022 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
usd | |
| CY2022 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
usd | |
| CY2022 | satt |
Right Of Use Asset
RightOfUseAsset
|
usd | |
| CY2022Q4 | us-gaap |
Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
|
usd | |
| CY2021Q4 | us-gaap |
Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
|
usd | |
| CY2022 | satt |
Number Warrant Granted
NumberWarrantGranted
|
shares | |
| CY2022 | satt |
Average Exercise Price Warrants Granted
AverageExercisePriceWarrantsGranted
|
||
| CY2022 | satt |
Number Of Warrant Exercised
NumberOfWarrantExercised
|
shares | |
| CY2022 | satt |
Average Exercise Price Warrant Exercised
AverageExercisePriceWarrantExercised
|
||
| CY2022 | satt |
Number Options Exercised
NumberOptionsExercised
|
shares | |
| CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
shares | |
| CY2022 | satt |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised
|
shares | |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
| CY2022 | us-gaap |
Payments For Loans
PaymentsForLoans
|
usd | |
| CY2022Q4 | us-gaap |
Future Minimum Sublease Rentals Sale Leaseback Transactions
FutureMinimumSubleaseRentalsSaleLeasebackTransactions
|
usd | |
| CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001661600 | |
| CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
0 | usd |
